NOVEL COMPOUNDS SYNERGIZE WITH VENETOCLAX TO TARGET KMT2A-REARRANGED ACUTE MYELOID LEUKEMIA

被引：0

作者：

Tregnago, C. ^{[1
]}

Benetton, M. ^{[1
]}

Da Ros, A. ^{[1
]}

Borella, G. ^{[1
]}

Longo, G. ^{[1
]}

Polato, K. ^{[1
]}

Francescato, S. ^{[1
]}

Biffi, A. ^{[1
]}

Pigazzi, M. ^{[1
]}

机构：

[1] Univ Padua, Dipartimento Salute Donna & Bambino, Div Ematooncol Pediat & Terapia Cellulare & Gen, Padua, Italy

来源：

HAEMATOLOGICA | 2022年 / 107卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P23

引用

页码：67 / 68

页数：2

共 50 条

[21] Nidogen-1, a Novel Player in KMT2A-Rearranged Pediatric Acute Myeloid Leukemia Patients, Expressed in the Leukemic Stem Cell
Vanhooren, Jolien
Deneweth, Larissa
Pagliaro, Luca
Ren, Zhiyao
Depreter, Barbara
Hofmans, Mattias
De Moerloose, Barbara
Lammens, Tim
BLOOD, 2024, 144 : 6134 - 6135
[22] Enhancer-activated RET confers protection against oxidative stress to KMT2A-rearranged acute myeloid leukemia
Frett, Brendan
Stephens, Kimberly E.
Koss, Brian
Melnyk, Stepan
Farrar, Jason
Saha, Debasmita
Roy Choudhury, Samrat
CANCER SCIENCE, 2024, 115 (03) : 963 - 973
[23] ACUTE ENCEPHALOPATHY FOLLOWING TUMOR LYSIS SYNDROME IN AN INFANT WITH KMT2A-REARRANGED LEUKEMIA
Murasawa, Reina
Ashiarai, Miho
Yoshihara, Hiroki
Umehara, Naoki
Nakatani, Ryo
Ono, Rintaro
Hosoya, Yosuke
Yokoyama, Mina
Nozaki, Taiki
Hasegawa, Daisuke
PEDIATRIC BLOOD & CANCER, 2022, 69
[24] Myeloid lineage switch in KMT2A-rearranged acute lymphoblastic leukemia treated with lymphoid lineage-directed therapies
Bataller, Alex
Abuasab, Tareq
McCall, David
Wang, Wei
Cuglievan, Branko
Issa, Ghayas C.
Jabbour, Elias
Short, Nicholas
DiNardo, Courtney D.
Tang, Guilin
Garcia-Manero, Guillermo
Kantarjian, Hagop M.
Sasaki, Koji
HAEMATOLOGICA, 2024, 109 (01) : 293 - 297
[25] Targeting HDAC9 Contributes to Degradation of MLL Fusion Oncoproteins in KMT2A-Rearranged Acute Myeloid Leukemia
Zhou, Yutong
Qian, Yu
Jin, Jie
BLOOD, 2023, 142
[26] Coexistence and Prognostic Significance of EVI1 Expression and Driver Mutations in KMT2A-Rearranged Acute Myeloid Leukemia
Matsuo, Hidemasa
Yoshida, Kenichi
Nakatani, Kana
Kamikubo, Yasuhiko
Tomizawa, Daisuke
Taga, Takashi
Kiyokawa, Nobutaka
Ogawa, Seishi
Meggendorfer, Manja
Haferlach, Claudia
Adachi, Souichi
BLOOD, 2019, 134
[27] LILRB4 Is a Novel Target for KMT2A Rearranged Acute Leukemia
Smith, Caroline
Huang, Ryan
Xie, Jingjing
Liu, Xiaoye
He, Yubo
Ludwig, Kathleen
Klesse, Laura
Zhang, Chengcheng
John, Samuel
BLOOD, 2022, 140 : 7423 - 7424
[28] COMBINATORIAL IMMUNOTHERAPEUTIC AND TARGETED KINASE INHIBITION APPROACH IN KMT2A-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIA
Niswander, Lisa
Mcclellan, Samantha
Shraim, Rawan
Falkenstein, Catherine
Yarnell, Michael
Meadows, Christina
Fry, Terry
Tasian, Sarah
PEDIATRIC BLOOD & CANCER, 2023, 70 : S117 - S117
[29] Outcomes of Venetoclax and Hypomethylating Agents (HMA) in Adult Patients with KMT2A-Rearranged Leukemias
Ball, Brian
Arslan, Shukaib
Koller, Paul
Murata-Collins, Joyce
Afkhami, Michelle
Pillai, Raju
Gaal, Karl
Salhotra, Amandeep
Al Malki, Monzr M.
Aribi, Ahmed
Ali, Haris
Otoukesh, Salman
Amanam, Idoroenyi
Nakamura, Ryotaro
Smith, Eileen P.
Stewart, Forrest
Marcucci, Guido
Pullarkat, Vinod A.
Aldoss, Ibrahim
BLOOD, 2021, 138
[30] Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia
Burmeister, Thomas
Stroeh, Aeint-Steffen
Kehden, Britta
Trautmann, Heiko
Meyer, Claus
Marschalek, Rolf
Larghero, Patrizia
Schwartz, Stefan
Steffen, Bjoern
Spriewald, Bernd
Heinicke, Thomas
Jaekel, Nadja
Westermann, Joerg
Nachtkamp, Kathrin
Viardot, Andreas
Topp, Max S.
Neumann, Martin
Baldus, Claudia D.
Goekbuget, Nicola
Brueggemann, Monika
LEUKEMIA, 2024, 38 (07) : 1600 - 1603

← 1 2 3 4 5 →